{"id":"https://openalex.org/W2417633671","doi":null,"title":"[Sensitivity of Plasmodium falciparum to quinolines and therapeutic strategies: comparison of the situation in Africa and Madagascar between 1983 and 1986].","display_name":"[Sensitivity of Plasmodium falciparum to quinolines and therapeutic strategies: comparison of the situation in Africa and Madagascar between 1983 and 1986].","alternate_titles":[],"publication_year":1987,"publication_date":"1987-01-01","ids":{"openalex":"https://openalex.org/W2417633671","mag":"2417633671","pmid":"https://pubmed.ncbi.nlm.nih.gov/3319258"},"language":"fr","primary_location":{"id":"pmid:3319258","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3319258","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bulletin de la Societe de pathologie exotique et de ses filiales","raw_type":"Comparative Study"},"parent_works":[],"lineage":["https://openalex.org/W2417633671"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109250570","display_name":"Jacques Le Bras","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210145170","display_name":"H\u00f4pital Bichat-Claude-Bernard","ror":"https://ror.org/03fdnmv92","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210145170"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J Le Bras","raw_affiliation_strings":["Centre National de R\u00e9f\u00e9rence pour la Chimiosensibilit\u00e9 du Paludisme, H\u00f4pital Claude-Bernard, Paris"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre National de R\u00e9f\u00e9rence pour la Chimiosensibilit\u00e9 du Paludisme, H\u00f4pital Claude-Bernard, Paris","institution_ids":["https://openalex.org/I4210145170"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101415714","display_name":"Fran\u00e7ois Simon","orcid":"https://orcid.org/0000-0002-4345-6249","observed_orcids":["https://orcid.org/0000-0002-4345-6249"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"F Simon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019869277","display_name":"J A Ramanamirija","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J A Ramanamirija","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030657193","display_name":"M.B. Calmel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M B Calmel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028871713","display_name":"Isabelle Hatin","orcid":"https://orcid.org/0000-0002-4428-3079","observed_orcids":["https://orcid.org/0000-0002-4428-3079"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"I Hatin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027761066","display_name":"Philippe Deloron","orcid":"https://orcid.org/0000-0003-4705-2484","observed_orcids":["https://orcid.org/0000-0003-4705-2484"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P Deloron","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"J Porte","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J Porte","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034072226","display_name":"Herv\u00e9 Marchais","orcid":"https://orcid.org/0000-0002-7845-0680","observed_orcids":["https://orcid.org/0000-0002-7845-0680"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"H Marchais","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087535778","display_name":"Clausse Jl","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J L Clausse","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5002905976","display_name":"Biaud Jm","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J M Biaud","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.2374,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":{"value":0.79268763,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"80","issue":"3 Pt 2","first_page":"477","last_page":"489"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10091","display_name":"Malaria Research and Control","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10091","display_name":"Malaria Research and Control","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12685","display_name":"Phytochemical compounds biological activities","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12878","display_name":"Pharmaceutical Quality and Counterfeiting","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/plasmodium-falciparum","display_name":"Plasmodium falciparum","score":1.0},{"id":"https://openalex.org/keywords/chloroquine-resistance","display_name":"chloroquine resistance","score":0.8500000238418579},{"id":"https://openalex.org/keywords/amodiaquine","display_name":"amodiaquine","score":0.8410000205039978},{"id":"https://openalex.org/keywords/quinine","display_name":"quinine","score":0.8339999914169312},{"id":"https://openalex.org/keywords/mefloquine","display_name":"mefloquine","score":0.996999979019165},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.5149999856948853},{"id":"https://openalex.org/keywords/in-vitro-drug-sensitivity","display_name":"in vitro drug sensitivity","score":0.753000020980835},{"id":"https://openalex.org/keywords/in-vivo-efficacy","display_name":"in vivo efficacy","score":0.8820000290870667},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.6179999709129333},{"id":"https://openalex.org/keywords/treatment-regimens","display_name":"treatment regimens","score":0.6420000195503235},{"id":"https://openalex.org/keywords/disease-surveillance","display_name":"disease surveillance","score":0.6930000185966492},{"id":"https://openalex.org/keywords/africa","display_name":"Africa","score":0.6150000095367432},{"id":"https://openalex.org/keywords/madagascar","display_name":"Madagascar","score":0.7269999980926514},{"id":"https://openalex.org/keywords/central-africa","display_name":"Central Africa","score":0.7070000171661377},{"id":"https://openalex.org/keywords/cameroon","display_name":"Cameroon","score":0.5960000157356262}],"concepts":[{"id":"https://openalex.org/C2776992834","wikidata":"https://www.wikidata.org/wiki/Q239569","display_name":"Amodiaquine","level":4,"score":0.9377077221870422},{"id":"https://openalex.org/C2777425658","wikidata":"https://www.wikidata.org/wiki/Q422438","display_name":"Chloroquine","level":3,"score":0.899404764175415},{"id":"https://openalex.org/C2777617192","wikidata":"https://www.wikidata.org/wiki/Q189522","display_name":"Quinine","level":3,"score":0.8398298025131226},{"id":"https://openalex.org/C2778371730","wikidata":"https://www.wikidata.org/wiki/Q311383","display_name":"Plasmodium falciparum","level":3,"score":0.8035553693771362},{"id":"https://openalex.org/C2777199930","wikidata":"https://www.wikidata.org/wiki/Q736270","display_name":"Mefloquine","level":4,"score":0.7982518672943115},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.574026346206665},{"id":"https://openalex.org/C2778048844","wikidata":"https://www.wikidata.org/wiki/Q12156","display_name":"Malaria","level":2,"score":0.5619006752967834},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.532916784286499},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.5294133424758911},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4944732189178467},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.43799978494644165},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3841197192668915},{"id":"https://openalex.org/C42972112","wikidata":"https://www.wikidata.org/wiki/Q170201","display_name":"Veterinary medicine","level":1,"score":0.33686089515686035},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28063446283340454},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1902008354663849},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.08730572462081909},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.08493185043334961}],"mesh":[{"descriptor_ui":"D000655","descriptor_name":"Amodiaquine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D000655","descriptor_name":"Amodiaquine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000810","descriptor_name":"Angola","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000962","descriptor_name":"Antimalarials","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002050","descriptor_name":"Burkina Faso","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002163","descriptor_name":"Cameroon","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002738","descriptor_name":"Chloroquine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004351","descriptor_name":"Drug Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008270","descriptor_name":"Madagascar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008288","descriptor_name":"Malaria","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008288","descriptor_name":"Malaria","qualifier_ui":"Q000469","qualifier_name":"parasitology","is_major_topic":true},{"descriptor_ui":"D010963","descriptor_name":"Plasmodium falciparum","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011803","descriptor_name":"Quinine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015767","descriptor_name":"Mefloquine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:3319258","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3319258","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bulletin de la Societe de pathologie exotique et de ses filiales","raw_type":"Comparative Study"},{"id":"mag:2417633671","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3319258","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2396351265","https://openalex.org/W2420499021","https://openalex.org/W2068301364","https://openalex.org/W2052690959","https://openalex.org/W2474865322","https://openalex.org/W2425496606","https://openalex.org/W2415986179","https://openalex.org/W2107287565","https://openalex.org/W2403631345","https://openalex.org/W1932740040"],"abstract_inverted_index":{"One":[0],"thousand":[1],"and":[2,14,22,32,46,49,61,73,90,104,113,118,155,169,180],"twenty":[3],"six":[4],"P.":[5,183],"falciparum":[6,184],"strains":[7],"isolated":[8],"from":[9],"cases":[10,127],"imported":[11],"in":[12,17,26,35,71,74,107,128,152,156,187],"France":[13],"field":[15,41],"surveys":[16],"four":[18],"regions":[19],"of":[20,115,146,151,159,164,172,182],"Africa":[21,188],"Madagascar":[23],"were":[24,38,85,120],"studied":[25],"vitro":[27,72,153],"against":[28],"chloroquine,":[29],"monodesethylamodiaquine,":[30],"quinine":[31,160],"mefloquine,":[33],"917":[34],"vivo":[36,157],"tests":[37],"performed":[39],"during":[40,63],"studies":[42],"with":[43,100],"chloroquine":[44,69,82,116],"(10":[45],"25":[47,80],"mg/kg)":[48],"amodiaquine":[50,84,135],"(10,":[51],"25,":[52],"35":[53,147],"mg/kg).":[54],"In":[55,95,131],"Madagascar,":[56],"the":[57,64,125,167,175],"chemoresistance":[58,98],"remained":[59,136],"low":[60],"stable":[62],"study":[65],"period,":[66],"concerning":[67],"mostly":[68],"(11%":[70],"vivo)":[75],"without":[76],"obvious":[77,190],"geographical":[78],"variation.":[79],"mg/kg":[81],"or":[83],"satisfactory":[86],"as":[87,138],"respectively":[88],"first":[89],"second":[91],"line":[92],"therapeutic":[93,193],"regimen.":[94,194],"Central":[96],"Africa,":[97],"emerged":[99],"an":[101],"epidemic":[102],"profile":[103],"increased":[105],"dramatically":[106],"disseminated":[108],"urban":[109],"focus.":[110],"High":[111],"level":[112],"prevalence":[114],"resistance":[117],"multiresistance":[119],"observed":[121],"few":[122],"months":[123],"after":[124],"index":[126],"these":[129],"foci.":[130],"South":[132],"West":[133],"Cameroon,":[134],"efficient":[137],"curative":[139],"treatment":[140],"but":[141],"only":[142],"at":[143],"a":[144,162],"dose":[145],"mg/kg/5":[148],"days.":[149],"Decrease":[150],"sensitivity":[154,186],"efficacy":[158],"is":[161,189],"matter":[163],"concern.":[165],"Given":[166],"heterogeneous":[168],"evolutive":[170],"situation":[171],"drug":[173,185],"resistance,":[174],"need":[176],"for":[177],"epidemiological":[178],"surveillance":[179],"monitoring":[181],"to":[191],"adjust":[192]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2417633671","counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
